The LipiFlow® Thermal Pulsation System is the only FDA cleared device to treat Meibomian Gland Dysfunction which plays a role in 86% of Dry Eye. It consists of a Console and a single-use sterile device, known as the Activator, and has a drug-free mechanism of action. Eye care professionals use the LipiFlow System to treat MGD patients in-office with confidence and efficiency.
The Lipiflow System represents more than 10 years of dedicated research and is protected by more than 30 patents. A phased pressure profile with adaptive force equalization and proximal-to-distal peristaltic motion evacuates gland contents as the inner lid is gently heated.